← Weekly issues
Week of 2026-10-05
2026-W41 · 2026-10-05 – 2026-10-11 · 486 findings
observational
Uncertainty redefines biological age
Biological age uncertainty (BAU), the width of predicted-age distributions, is only weakly correlated with biological age gap and independently predicts mortality, multimorbidity, and healthspan loss, tying reduced coherence of aging signals across molecules and organs to future health vulnerability.
news report
FDA Leaders Name Longevity a Priority at ARDD
At ARDD in Boston, FDA senior officials announced plans to include aging in the agency’s regulatory science agenda and discussed how longevity therapies could be regulated.
review
"Ozempic Face" and Facial Aging.
Rapid weight loss from GLP-1 receptor agonists can produce an accelerated facial-aging appearance ("Ozempic face") via volume deflation, skin laxity, and loss of structural support, warranting dermatologic counseling and tissue-preservation strategies.
trial early
Digital STEADI Efficacy
A comprehensive digital fall-prevention program (Digital STEADI) delivered via gen-AI conversational agents with human oversight is being evaluated for efficacy in increasing access and adherence and reducing fall risk among community-dwelling older adults, including those with mild cognitive impairment.
trial early
Vibegron for ENergy Thinking and Resilience in Aging
A 12-week randomized, double-blind, placebo-controlled trial will test whether vibegron (GEMTESA) improves energy metabolism, cardiometabolic risk factors, and physical and cognitive function in middle-aged and older adults with obesity.
trial early
Role of Menopause in Thermoregulation
Investigators will test whether low estrogen after menopause, on top of aging, impairs thermoregulatory responses to heat stress and helps explain why women over 65 fare worst in heat waves.
observational
Westlake Longevity Cohort
The Westlake Longevity Cohort (We-Longevity) will prospectively characterize multi-omics molecular signatures and dynamic trajectories of healthy longevity in Chinese centenarians, nonagenarians, and seniors, culture their gut microbiota, and link diet and lifestyle to those molecular profiles for personalized recommendations.
news report
A New Metric for Overall Senescent Cell Burden
Researchers developed a deep learning-based SASP Score biomarker that quantifies overall circulating senescent cell burden from blood-borne senescence-associated secretory phenotype factors.
observational
Compromised Elastin Network Load Transfer in Aging Human Aorta.
In purified human thoracic aortic elastin, aging in males is linked to fiber fragmentation, increased waviness, reduced lamellar continuity, and lower tensile stiffness, whereas female elastin networks show relative structural and mechanical preservation.
preclinical
Senotherapeutic potential against xeroderma pigmentosum.
Senolytics (BCL-2-like and HSP90 inhibitors) and senomorphics (JAK inhibitors and curcuminoids) clear or suppress UV-induced senescence and SASP in XP patient-derived melanocytes, suggesting a senotherapeutic approach to XP photoaging.
review
AI-Based Measurement Tools for Intrinsic Capacity in Older Adults: Scoping Review.
AI-based digital devices, digital biomarkers, and machine/deep-learning methods can support continuous, real-world measurement of WHO intrinsic capacity domains—especially cognition and locomotion—but vitality, hearing, and multidomain IC assessment remain underdeveloped and need standardization and external validation.
review
Mechanical signals in aging: mechanisms and therapeutic strategies.
Cellular mechanics and mechanotransduction critically regulate senescence initiation and progression, and mechanics-based interventions (stimulation, microenvironment remodeling, targeted mechanotransduction modulation) hold therapeutic potential for aging and regenerative medicine.
review
Brain aging clocks: From methodological advances to cellular mechanisms.
Brain aging clocks have evolved from simple global metrics into multi-modal, cellular-resolution tools that quantify biological brain age, implicate cellular senescence and related mechanisms in accelerated neural aging, and support earlier prediction and targeted intervention for neurodegenerative disease.
review
Is amyloid beta peptide a driver of inflammaging?
Amyloid beta may drive aging-related subclinical neuroinflammation (inflammaging) through cell-type-specific mechanisms while also retaining beneficial physiological roles, making Aβ-associated inflammaging a potential early-intervention target in age-related neurodegeneration.
observational
Purpose in Life and Functional Reserve in a Memory Clinic Sample.
Higher purpose in life was strongly associated with better functional reserve—maintaining IADL function better than expected given cognitive status—in a memory clinic sample, with only partial attenuation by Big Five personality for patient-rated outcomes.
review
Linking the exposome to frailty: pathways, mechanisms, clinical implications, and prevention.
Exposome exposures—socioeconomic disadvantage, loneliness, pollution, ultra-processed foods, and sedentary behaviour—contribute to frailty via inflammation, mitochondrial dysfunction, microbiome dysbiosis and epigenetic aging, while Mediterranean-style diets, physical activity, social connection and green environments are protective and clinically actionable.
review
Adropin signaling pathways in metabolic and non-metabolic disorders.
Adropin is a pleiotropic ENHO-encoded peptide hormone, typically reduced in obesity, metabolic disease, atherosclerosis, heart failure, and cognitive aging, that acts via GPR19 and NB-3/CNTN6 to improve insulin action, mitochondrial fuel selection, endothelial NO bioavailability, and blood-brain barrier integrity.
other
Peanut Sip Feeding Protocol
A peanut sip-feeding protocol is framed to study peanut protein—whose digestibility is described as similar to animal protein—as a means of probing reduced anabolic responsiveness to dietary protein in older adults.
observational
Relationship Between Albumin/Creatine Ratio, B12, Folate, and Frailty Index
Investigators aim to determine whether preoperative albumin/creatinine ratio, B12, folate, ferritin, hemogram, sedimentation rate, and CRP associate with Frailty Scale Version 9 scores in patients undergoing gastrointestinal malignancy surgery, to flag modifiable frailty factors.
trial early
Blood Flow Restriction Training in Acute Geriatric Rehabilitation
Low-intensity blood flow restriction (occlusion) training is being tested for feasibility and effects on general health as a safer alternative to high-load resistance training for muscle mass and strength in older adults in acute geriatric rehabilitation.
trial early
Transcranial Pulse Stimulation of the Brain
A sham-controlled RCT will test whether low-intensity transcranial pulse stimulation (TPS) of key brain regions improves cognitive function and brain structure/function in typically aging older adults and patients with mild dementia.
trial early
Walking Sensation Study
Walkasins sensory neuroprosthesis is hypothesized to improve automaticity of complex walking and lower cognitive demand (prefrontal activity, dual-task cost, gait variability) in older adults with foot sensory impairment.
observational
Taining Golden Lake Comprehensive Chronic Disease Management Initiative
Investigators will enroll at least 20,000 adults in Taining County, China, into a 3-year prospective cohort with questionnaires, labs, imaging, and a biobank to map chronic-disease risk, multimorbidity and aging syndromes, and to build a rural chronic-disease management model.
trial early
Multicomponent Prehabilitation in Older Adults With Breast Cancer
A multicomponent prehabilitation program combining exercise, nutritional optimization, and comprehensive geriatric assessment is being evaluated to improve functional status, clinical outcomes, and quality of life in older adults with breast cancer, with biological frailty markers explored as predictors of response.
other
AKG and Brain Health in Aging
A research proposal hypothesizes that AKG supplementation will improve neurovascular coupling responses and cognitive performance in older adults by reducing age-related oxidative stress in neurovascular unit cells.
trial early
Women in Action: A Multicomponent Intervention for Older Women
A 16-week multicomponent program of supervised strength, aerobic, and balance training plus psychoeducational and nutrition workshops is being tested for feasibility and preliminary effects on handgrip strength and secondary physical, dietary, and psychosocial outcomes in women aged 55–75.
trial early
VICIA FABA PEPTIDES AND RESISTANCE TRAINING IN THE ELDERLY
A planned double-blind RCT will test whether 2.5 g/day Vicia faba-derived peptides plus four weeks of supervised resistance training improve muscle strength, body composition, function, frailty, and related outcomes in adults aged 60+, and whether habitual activity level modifies response.
other
Sex Hormones and Aging
A planned study will compare postmenopausal women with versus without hormone therapy to test how estradiol status shapes age-related neuromuscular decline and adaptations to resistance training.
observational
Brazilian Registry of Menopausal Health
A Brazilian national registry will study health and quality of life in people aged 35–65 in the menopausal transition or postmenopause, hypothesizing that regional and socioeconomic disparities shape menopause-related health, knowledge, and perception.
expert media
The end of Alzheimer’s?
Attia discusses an Alzheimer's prevention strategy that is currently in clinical trials, framing it as potentially transformative.
news report
The Biomarkers That Predict Mortality Risk
A research summary reports that researchers identified key biomarkers strongly linked to all-cause mortality, including four measurements with independent predictive power beyond chronological age.
news report
Fight Aging! Newsletter, October 5th 2026
Fight Aging! reports that PD-L1 blockade in the brain restores measures of glial cell function and argues that mTOR should not be treated as a single pharmaceutical target because biological context matters.
review
Experimental model systems to study vascular aging.
In vitro (primary and iPSC 2D/3D cultures, spheroids, organoids, vessel-on-chip) and in vivo (genetically engineered mice and disease models) experimental systems, with functional readouts such as FMD and PWV, are central tools for studying vascular aging mechanisms and testing therapies.
review
Mechanisms of Hematopoietic Stem Cell Aging and Emerging Rejuvenation Strategies.
Hematopoietic stem cell aging is driven by niche and cell-intrinsic changes—genomic instability, epigenetic dysregulation, mitochondrial dysfunction, and inflammatory cues—producing myeloid-biased, functionally compromised HSC expansion that emerging epigenetic, metabolic, and anti-inflammatory rejuvenation strategies aim to reverse.
review
Wound Healing, Senescence, and Senotherapeutics.
Senescent cells play pleiotropic, context-dependent roles in normal and impaired wound healing, and senotherapeutics that clear or suppress them can restore regenerative capacity in aged and chronically injured skin.
review
Cellular senescence: six decades of discovery and reinvention.
Cellular senescence has evolved from Hayflick’s replicative endpoint into a stress-response program that regulates tissue homeostasis, drives age-related pathology, and is now a clinically actionable therapeutic target via senotherapeutics.
review
Micronutrients and omega-3 PUFAs to promote healthy ageing: informing a physiology-based complementation strategy.
Optimizing micronutrient status (vitamins B, C, D, E, iron, selenium, zinc) and EPA+DHA from midlife, via risk assessment and targeted repletion beyond diet alone, should be integral to healthy-ageing strategies because common insufficiencies accelerate mitochondrial dysfunction, inflammageing, and functional decline.
review
The Role of EVs in the Aging Hematopoietic System.
Aging remodels bone-marrow EV biogenesis and cargo—especially from senescent MSCs and osteoblasts—driving niche dysfunction, recipient senescence, and myeloid-biased hematopoiesis, while EVs from young or pluripotent stem cells can restore aged HSPC function and attenuate inflammaging.
news report
Rejuvenation Roundup September 2026
A September 2026 rejuvenation roundup argues that which generation is the last to die of age-related diseases depends on the pace of rejuvenation technology development and deployment.